The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AETNA INC NEW | COM | 00817Y108 | 1,804 | 26,300 | SH | SOLE | 0 | 26,300 | 0 | 0 | |
ALLERGAN INC | COM | 018490102 | 5,321 | 47,900 | SH | SOLE | 0 | 47,900 | 0 | 0 | |
AMGEN INC | COM | 031162100 | 9,560 | 83,800 | SH | SOLE | 0 | 83,800 | 0 | 0 | |
CARDINAL HEALTH INC | COM | 14149Y108 | 4,637 | 69,400 | SH | SOLE | 0 | 69,400 | 0 | 0 | |
COMMUNITY HEALTH SYS INC NEW | COM | 203668108 | 569 | 14,500 | SH | OTR | 1 | 0 | 0 | 14,500 | |
COMMUNITY HEALTH SYS INC NEW | COM | 203668108 | 10,960 | 279,100 | SH | SOLE | 0 | 279,100 | 0 | 0 | |
COOPER COS INC | COM NEW | 216648402 | 4,755 | 38,400 | SH | SOLE | 0 | 38,400 | 0 | 0 | |
EDWARDS LIFESCIENCES CORP | COM | 28176E108 | 2,676 | 40,700 | SH | SOLE | 0 | 40,700 | 0 | 0 | |
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 256 | 9,400 | SH | OTR | 1 | 0 | 0 | 9,400 | |
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 4,121 | 151,071 | SH | SOLE | 0 | 151,071 | 0 | 0 | |
GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 14,629 | 274,000 | SH | SOLE | 0 | 274,000 | 0 | 0 | |
GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 619 | 11,600 | SH | OTR | 1 | 0 | 0 | 11,600 | |
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 4,461 | 384,200 | SH | SOLE | 0 | 384,200 | 0 | 0 | |
KYTHERA BIOPHARMACEUTICALS I | COM | 501570105 | 2,951 | 79,000 | SH | SOLE | 0 | 79,000 | 0 | 0 | |
MAGELLAN HEALTH SVCS INC | COM NEW | 559079207 | 3,720 | 62,100 | SH | SOLE | 0 | 62,100 | 0 | 0 | |
MYLAN INC | COM | 628530107 | 833 | 19,200 | SH | OTR | 1 | 0 | 0 | 19,200 | |
MYLAN INC | COM | 628530107 | 11,948 | 275,300 | SH | SOLE | 0 | 275,300 | 0 | 0 | |
NOVO-NORDISK A S | ADR | 670100205 | 5,765 | 31,200 | SH | SOLE | 0 | 31,200 | 0 | 0 | |
ORTHOFIX INTL N V | COM | N6748L102 | 484 | 21,200 | SH | OTR | 1 | 0 | 0 | 21,200 | |
ORTHOFIX INTL N V | COM | N6748L102 | 10,488 | 459,600 | SH | SOLE | 0 | 459,600 | 0 | 0 | |
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 341 | 119,700 | SH | SOLE | 0 | 119,700 | 0 | 0 | |
SANOFI | SPONSORED ADR | 80105N105 | 6,275 | 117,000 | SH | SOLE | 0 | 117,000 | 0 | 0 | |
TEVA PHARMACEUTICAL INDS LTD | ADR | 881624209 | 1,006 | 25,100 | SH | OTR | 1 | 0 | 0 | 25,100 | |
TEVA PHARMACEUTICAL INDS LTD | ADR | 881624209 | 12,834 | 320,200 | SH | SOLE | 0 | 320,200 | 0 | 0 | |
XENOPORT INC | COM | 98411C100 | 1,390 | 241,800 | SH | SOLE | 0 | 241,800 | 0 | 0 |